Recombinant Human COPT1 Protein，His

COPT1 (Copper Transporter 1) is a transmembrane protein that plays a crucial role in the homeostasis of copper, an essential trace element necessary for various biological processes. Aberrations in copper transport can lead to disorders such as Menkes disease and Wilson's disease, which are characterized by copper deficiency and accumulation, respectively. The study of COPT1 recombinant proteins has gained prominence due to their potential therapeutic applications and the need to understand copper metabolism at a molecular level. Functionally, COPT1 mediates the uptake of cupric ions across cellular membranes, making it vital for cellular processes such as mitochondrial function, antioxidant defense, and enzyme activity, where copper acts as a cofactor. Recent research efforts have focused on elucidating the structural and functional characteristics of COPT1 through recombinant techniques, facilitating insights into its transport mechanisms and regulation. By producing and characterizing COPT1 as a recombinant protein, scientists aim to explore its interaction with ligands and other proteins, paving the way for the development of targeted therapies for various copper-related disorders. Additionally, the generation of recombinant COPT1 can serve as a valuable tool for high-throughput screening of small molecule modulators, which could lead to advancements in drug development. Overall, the study of COPT1, particularly through the lens of recombinant protein research, holds significant implications for both our understanding of metal ion homeostasis and the development of clinical interventions for copper metabolism disorders.